Advertisement

Topics

Search Results for "Arbonne Annual Revenue 2012"

07:10 EDT 6th May 2016 | BioPortfolio

Matching Channels

macitentan

Macitentan (Opsumit®) is a novel dual endothelin receptor antagonist (ERA) that resulted from a tailored drug discovery process with the target to develop an ERA optimized for efficacy and safet...

Medtronic

With annual sales reaching $15 billion in 2010, Medtronic is the 4th largest medical devices company in the world (based on annual sales). The device portfolio of Medtronic is broad; covering card...

OxyContin

OxyContin, an narcotic <!--LGfEGNT2Lhm-->analgesic produced by Purdue Pharma LP, nets $3m in <!--LGfEGNT2Lhm-->sales annually, placing it 8th in the world for annual sales. OxyContin i...

ATX-MS-1467 for patients with multiple sclerosis (MS)

ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the ...

Rheumatoid arthritis

Rheumatoid arthritis (RA) is a chronic systemic disease characterized by progressive joint deformity and joint destruction driven by synovial inflammation and hyperplasia in which cytokines play cen...

Matching News

Insys Therapeutics: Is The Price Downfall Justified ?

Insys Therapeutics , headquartered in Chandler, Arizona develops cancer support drugs based on opioids. Since the authorization of their first product in 2012, the company has been acknowledging an im...

BRIEF-Santhera Pharmaceuticals Holding Q4 net revenue at 1.9 mln CHF

* Net revenues in Q4 2015 were 1.9 million Swiss francs ($1.9 million), representing 44 pct of reported annual revenue and a 136 pct increase over the average quarterly net sale for Q1-Q3 2015

IBA says revenue up 25 pct in Q3 y/y

BRUSSELS, Nov 17 (Reuters) - Belgian proton therapy group IBA said on Tuesday its revenue grew by 25 percent year-on-year in the third quarter to 188.9 million euros ($201.44 mln) and reported a 305-m...

New Report: Sexually Transmitted Disease Surveillance 2012

This report presents statistics and trends for sexually transmitted diseases (STDs) in the United States through 2012. This annual publication is intended as a reference document for policy makers, ...

Regenerative medicine conference to bring world-leading scientists together

The Regener8 Annual Conference 2012 is a one day meeting with a focus on the translation and commercialisation of regenerative therapies. The theme for 2012 will be focused around progressing regenera...

Amid investor criticism, AstraZeneca considers link between executive pay and revenue goal

The company aims to hit $45 billion in revenue by 2023 but has forecast lower revenue and earnings per share this year. 

Haivision Leads Enterprise Video Market with Record Annual Revenue of $56.4 Million

MONTREAL, Nov. 18, 2015 (GLOBE NEWSWIRE) -- Haivision, a market leader in video streaming and media management solutions, today announced revenue results for the company's fiscal year ending October ...

Plexus Reports Record Revenue of $2.7 Billion and 12% Annual Growth for Fiscal 2015

Fiscal fourth quarter revenue of $669 millionDiluted quarterly EPS of $0.70Initiates fiscal first quarter 2016 revenue guidance of $600 - $625 million with diluted EPS of $0.41 to $0.48 NEENAH...

Matching PubMed Articles

Reported Diabetes Mellitus Prevalence Rates in the Colombia Healthcare System from 2009 to 2012: Analysis by Regions Using Data of the Official Information Sources.

The objective of this study was to describe the reported diabetes mellitus (DM) prevalence rates of the 20-79-year-old population in Colombia from 2009 to 2012 reported by the healthcare system. Infor...

Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001-2012.

The aim of this study was to evaluate systemic sclerosis (SSc) hospitalizations through a retrospective population-based study analyzing administrative data during 2001-2012 in Sardinia, an Italian re...

Early Appropriate Care: A protocol to standardize resuscitation assessment and to expedite fracture care reduces hospital stay and enhances revenue.

We hypothesized that a standardized protocol for fracture care would enhance revenue by reducing complications and length of stay.

The Early Years of Practice: An Assessment of Operative Efficiency and Cost of Free Flap and Implant Breast Reconstruction at an Academic Institution.

Objective The purpose of this study was to evaluate the short-term costs, and financial implications of improvements in operative efficiency of free flap and implant-based breast reconstruction with...

Impacts of Contrasting Alfalfa Production Systems on the Drivers of Carabid Beetle (Coleoptera: Carabidae) Community Dynamics.

Growing concerns about the environmental consequences of chemically based pest control strategies have precipitated a call for the development of integrated, ecologically based pest management program...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement